{"name":"Intelligem Therapeutics Australia Pty Ltd.","slug":"intelligem-therapeutics-australia-pty-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiygJBVV95cUxQci1KaDBoQnI2a2FhTXBCbWJxamNkaGpZOHNSdTNJWURNRjc3MTJ4YUR2Rm1XczQtX2w2Wmg5SmJXY05VSERRbFdKUERFcS1fNFBjUmJicm5uMWE3QVF1TnRNT3ZRckxxYk11bU0wRE1kM2Y2bHJZNGJSOEh3UTZ2U19GUEdRbmsyWVc0S21rQWtnb2tqWGdpVkVUM0RWckdaM1diaXN3WmpSNExCTFNldTRMbmxLdmdfVlZYeHJJUFpxZ3VCT2Q5QkpPeGpSYm84ekQzZGs4NmxWYzFwSlZyVDlwa2RIWmk1RjV1amREemlDYzVhRF9nZzBORTFFQXEwcXdTeEVXajNSaUEtWC04bjlmTDRaRUl2MEVHQVJraXZRb3NzdktWUEVjc01oemJSSEtkZVlhazhLTURwTDNjbGlpSVVvcV9hakE?oc=5","date":"2026-03-25","type":"pipeline","source":"PR Newswire UK","summary":"Peptide Therapeutics Market Growing at 7.16% CAGR to Reach USD 70.20 Bn by 2031 Driven by Rising Cancer Prevalence & Metabolic Disorder Burden, Reports Mordor Intelligence - PR Newswire UK","headline":"Peptide Therapeutics Market Growing at 7.16% CAGR to Reach USD 70.20 Bn by 2031 Driven by Rising Cancer Prevalence & Met","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-23","type":"pipeline","source":"PR Newswire","summary":"Formosa Pharmaceuticals Announces Licensing Agreement with Arrotex, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Sur","headline":"Formosa Pharmaceuticals Announces Licensing Agreement with Arrotex, for Commercialization of Clobetasol Propionate Ophth","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-28","type":"earnings","source":"simplywall.st","summary":"Island Pharmaceuticals Limited's (ASX:ILA) Profit Outlook - simplywall.st","headline":"Island Pharmaceuticals Limited's (ASX:ILA) Profit Outlook","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-09","type":"pipeline","source":"simplywall.st","summary":"Clarity Pharmaceuticals Ltd (ASX:CU6): Is Breakeven Near? - simplywall.st","headline":"Clarity Pharmaceuticals Ltd (ASX:CU6): Is Breakeven Near?","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-21","type":"pipeline","source":"simplywall.st","summary":"Vanda Pharmaceuticals Leads 3 Promising Penny Stocks - simplywall.st","headline":"Vanda Pharmaceuticals Leads 3 Promising Penny Stocks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNd3dIT3VBSlRfa0VUVGllLXhPSThNYkNyRklabmpSWklHT1hxbzlBTHA1V2NaYjc5QmwtUXhNeDk2S1Vid0xVOElFTXZ3Y3JmdmVRV3dOOXVVNFR2VFBDWDZtMXB1ZlZvM2F0Y2FUSVltX3NmeDNnVjFUNmJEZm5GeTRQWVZYRGJDNm5iMzVtUlYxOGN6SW5ibVZ4MFdlYlhwMThVcUtMMnctOXhnaE04?oc=5","date":"2025-11-12","type":"regulatory","source":"drugdiscoverytrends.com","summary":"Regulatory strategy reimagined: Three trends accelerating drug development - drugdiscoverytrends.com","headline":"Regulatory strategy reimagined: Three trends accelerating drug development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQZTlnQloyY1ZYdUVzZlliU012RXdteG0wX0p2akx3OGpNTE5wZ25MRHVCTk1tRmFaVkRsUE9Za2xNZHFOVmxNdktBb21kTDBVWGRrQXNKOHdwRUNIRXg1V3gzbEFnQTZDRVQ1Z1ZISm9IaU9BS3ZCaXFsbDlfTlR6SmQ4T1MwZUNheHZQX3VZMEVLRXNScmM3UzBYTl9uNHVBRjFETQ?oc=5","date":"2025-10-09","type":"pipeline","source":"intelligentinvestor.com.au","summary":"Telix Pharmaceuticals: The nuclear option - intelligentinvestor.com.au","headline":"Telix Pharmaceuticals: The nuclear option","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOR0lOZEdxZ0N2SUEtWExiQnd4YUx5R25GYzR0NUtKaWdvR3FIQmlpclpmWkdhRlpGVXpIX2ZRcV8zR2pKWVlyc0ppVFhjRERMem04X2dYSmo1eXhUQUJuLTFCbWwzVWtoTDVCQ2IyaEhOY0FLSWZRUFhjcUk0OW5sdUdyQldBRzJJLThjTURBYkwwRFVVZjZJeEIwTzZ2QQ?oc=5","date":"2025-09-23","type":"pipeline","source":"ig.com","summary":"ASX 200 healthcare stocks: ResMed, CSL, and Telix Pharmaceuticals in focus - ig.com","headline":"ASX 200 healthcare stocks: ResMed, CSL, and Telix Pharmaceuticals in focus","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQaVdYOEJnX3ZQR2RqRDRtUUtFYmU1eVNqQTMxdVh5TG96Smc1NjZzbDBVbENOS0txU2k5a1JhRVo4SVg1d29vZ19jbnc1MzlfWTBiWE9KQXJvZU9SVmJmd0NoZkhacDNZSTNjQWdTRU1TSkk5Nm1nNVp3M3NYbm1WVnJOckItYVFLOE95N3ZYNm5XQkpTNHVBY0s3em5KeHdjbkFrR3NTNjU?oc=5","date":"2025-06-04","type":"pipeline","source":"intelligentinvestor.com.au","summary":"Neuren Pharmaceuticals: Under the Microscope - intelligentinvestor.com.au","headline":"Neuren Pharmaceuticals: Under the Microscope","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNczN3RTNkSG00ZUxTUVNVNEt4WEFfLVFFTUhNR3JsRzI4aVk0dDVYOUd2bG1DWEtZWjFCbzdRQ2NPRTlnRkZlWEpETXg4cGVnbDltRUN5VFNFYlFyRGpWRjItSjM0STdmQk1oaTY0WW1OeS1VVWVQa0FuVUtQRENVV19sTnFrZ2s2TzVqeThWb3Itb3g5a2hMVGtDVEdPak10NmZzQTUtazFCdw?oc=5","date":"2025-02-01","type":"pipeline","source":"BioSpectrum Asia","summary":"APAC takes centre-stage in AI-driven drug discovery - BioSpectrum Asia","headline":"APAC takes centre-stage in AI-driven drug discovery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQLVgzVHJNQWk5UC1vQ0o5YTJUY0prX2RLa1Z2alNTc1RSMVJTbzVuX2FEdlZTYS1tYmViT1BNRThTandXVWJUb3Z4Q0xEOFpqVF9BMmZqVlptWlBMblFsQTlYSVM4R3BXckhETU5QaEhVajJSVUltU3FTUzAwQnBLeTA1RFIydEd3LWhPRXVGMEEwRGUtVEgxN1JzbWNhcTJMdno3bjBOSG9sNHRBSEhHNURxeVFYdw?oc=5","date":"2024-08-15","type":"pipeline","source":"Pharmaceutical Technology","summary":"Noumed’s Pharmaceutical Manufacturing Facility, Adelaide, Australia - Pharmaceutical Technology","headline":"Noumed’s Pharmaceutical Manufacturing Facility, Adelaide, Australia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQbzBodXpaRkpSbzB6cDBhZTA2N0xZVmJiMjlVYkpoNXNLTG5jZ2RXdlF2OU42eVFWc2w4TnB5bkJRVWo2YzBrd1J3Y2xUUkFQV2h6UDg4QkxUeVhqamJzTzY0d2xsNjRDZUJmaklzaUkwVHRjVXNJenUwdHhkX0lWVWlCYnppaXIycFV0b3hLYWVrN3hySlRzNjJLMTQ1VEl2bUE?oc=5","date":"2022-09-19","type":"pipeline","source":"Straits Research","summary":"Artificial Intelligence for Drug Discovery and Development Market Size & Share by 2034 - Straits Research","headline":"Artificial Intelligence for Drug Discovery and Development Market Size & Share by 2034","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}